According to LabCorp's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.35588. At the end of 2023 the company had a P/S ratio of 1.50.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.50 | -4.2% |
2022 | 1.56 | -16.3% |
2021 | 1.87 | 31.51% |
2020 | 1.42 | -0.34% |
2019 | 1.42 | 29.06% |
2018 | 1.10 | -29.65% |
2017 | 1.57 | 14.29% |
2016 | 1.37 | -4.95% |
2015 | 1.44 | -4.97% |
2014 | 1.52 | 12.63% |
2013 | 1.35 | -5.59% |
2012 | 1.43 | -7.1% |
2011 | 1.54 | -14.56% |
2010 | 1.80 | 7.18% |
2009 | 1.68 | 8.72% |
2008 | 1.54 | -25.08% |
2007 | 2.06 | -17.58% |
2006 | 2.50 | 22.14% |
2005 | 2.05 | -6.93% |
2004 | 2.20 | 22.08% |
2003 | 1.80 | 31.6% |
2002 | 1.37 | -47.2% |
2001 | 2.59 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
IDEXX Laboratories IDXX | 11.2 | 726.99% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 1.65 | 21.77% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
NeoGenomics
NEO | 3.03 | 123.28% | ๐บ๐ธ USA |
Qiagen QGEN | 4.68 | 244.90% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | 4.24 | 212.72% | ๐บ๐ธ USA |